astragaloside a has been researched along with Obesity in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Li, Z; Liu, Y; Luo, P; Wu, J; Yang, W; Yang, Y | 1 |
Bai, YY; Huang, F; Shi, HL; Wang, GR; Wang, XT; Wu, H; Wu, XJ; Yang, L; Yuan, JF | 1 |
Bi, Y; Jiang, P; Li, X; Ma, D; Wang, X; Wang, Y; Yang, J | 1 |
Gao, Y; Hu, ZB; Huang, F; Lan, YY; Qin, LY; Shi, HL; Wu, H; Wu, XJ; Zhang, BB | 1 |
4 other study(ies) available for astragaloside a and Obesity
Article | Year |
---|---|
The Astragaloside IV Derivative LS-102 Ameliorates Obesity-Related Nephropathy.
Topics: Animals; Benzoxazoles; Diabetic Nephropathies; Mice; Obesity; Saponins; Triazines; Triterpenes | 2022 |
Astragaloside IV ameliorates metabolic disorder in db/db obese mice as a PPARĪ³ antagonist.
Topics: 3T3-L1 Cells; Animals; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; PPAR gamma; RNA, Messenger | 2023 |
Astragaloside IV Prevents Obesity-Associated Hypertension by Improving Pro-Inflammatory Reaction and Leptin Resistance.
Topics: Animals; Hypertension; Inflammation; Leptin; Male; Obesity; Rats; Rats, Wistar; Saponins; Triterpenes | 2018 |
Astragaloside IV improves lipid metabolism in obese mice by alleviation of leptin resistance and regulation of thermogenic network.
Topics: Adipose Tissue; Animals; Body Weight; Cell Line; Diet, High-Fat; Gene Expression; Leptin; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Receptors, Leptin; Saponins; Thermogenesis; Triglycerides; Triterpenes; Weight Gain | 2016 |